The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma

Documenti analoghi

• Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
  di: Matsushita, Hirokazu, et al.
  Pubblicazione: (2020)
• Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
  di: Yukari Kobayashi, et al.
  Pubblicazione: (2020-05-01)
• Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma
  di: Imai, Yuichi, et al.
  Pubblicazione: (2018)
• Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing
  di: Karasaki, Takahiro, et al.
  Pubblicazione: (2017)
• P04.14 Multiomics analysis on primary and recurrent paired tumors reveals a possible immune evasion mechanism through reduced neoantigen expression in some glioma
  di: Nejo, T, et al.
  Pubblicazione: (2018)